Tricker A R, Kumar R, Siddiqi M, Khuroo M S, Preussmann R
Institute of Toxicology and Chemotherapy, German Cancer Research Center, Heidelberg.
Carcinogenesis. 1991 Sep;12(9):1595-9. doi: 10.1093/carcin/12.9.1595.
Antihelmintic treatment with piperazine (1,4-diazacyclohexane) for microfilarie parasitism results in the endogenous formation of piperazine-derived N-nitrosamines. The urinary excretion of these N-nitrosamines was determined by biochemical monitoring of 14 patients receiving 2 g piperazine citrate. The urinary excretion (mean +/- SD) of N-mononitrosopiperazine (MNPz) was 27.0 +/- 26.7 micrograms/day (range 0.6-96.0 micrograms/day). Trace levels of 0.73 +/- 0.92 micrograms/day N,N'-dinitrosopiperazine (DNPz) (range ND-2.8 micrograms/day) were also found in 7 of 14 urine samples. N-Nitroso-3-hydroxypyrrolidine (NHPYR), a metabolite of both MNPz and DNPz, was detected in 11 of 14 urine samples at a mean concentration of 1.74 +/- 1.72 micrograms/day (range ND-5.7 micrograms/day) and traces of N-nitrosodiethanolamine in two samples at levels of 0.3 and less than 0.1 micrograms/day. The results show that biochemical monitoring of urinary NHPYR may be a good indicator of endogenous MNPz formation. While DNPz was also detected in urine, conclusive validation for its endogenous formation could not be provided because no evidence was found for the presence of its major metabolite, N-nitroso-(2-hydroxyethyl)glycine in urine.
用哌嗪(1,4 - 二氮杂环己烷)治疗微丝蚴寄生虫感染会导致内源性生成哌嗪衍生的N - 亚硝胺。通过对14名接受2克枸橼酸哌嗪治疗的患者进行生化监测来测定这些N - 亚硝胺的尿排泄情况。N - 单亚硝基哌嗪(MNPz)的尿排泄量(均值±标准差)为27.0±26.7微克/天(范围为0.6 - 96.0微克/天)。在14份尿液样本中的7份里还发现了痕量的N,N'-二亚硝基哌嗪(DNPz),为0.73±0.92微克/天(范围为未检出 - 2.8微克/天)。14份尿液样本中的11份检测到了MNPz和DNPz的代谢产物N - 亚硝基 - 3 - 羟基吡咯烷(NHPYR),平均浓度为1.74±1.72微克/天(范围为未检出 - 5.7微克/天),两份样本中检测到痕量的N - 亚硝基二乙醇胺,水平分别为0.3和低于0.1微克/天。结果表明,对尿中NHPYR进行生化监测可能是内源性MNPz形成的良好指标。虽然尿液中也检测到了DNPz,但由于未发现其主要代谢产物N - 亚硝基 -(2 - 羟乙基)甘氨酸在尿液中的存在证据,所以无法提供其内源性形成的确凿验证。